转变TNBC治疗的范式:新兴的替代品,以capecitabine在后neoadjuvant设置后的替代品
Halima Abahssain1,2, Amine Souadka2,3,4, Rania Alem1,5
1Oncology and Medical Specialties Department, Valenciennes General Hospital, 59300 Valenciennes, France.
Current oncology (Toronto, Ont.)
|July 26, 2024
概括
像免疫疗法和PARP抑制剂这样的新疗法在初始治疗失败后正在改变三阴性乳腺癌 (TNBC) 的辅助治疗. 这些选择可能为残留疾病患者提供比capecitabine更好的结果.
科学领域:
- 在瘤学瘤学.
- 乳腺癌研究研究 乳腺癌研究
- 临床试验 临床试验
背景情况:
- 三阴性乳腺癌 (TNBC) 是一种具有有限治疗选择的侵袭性亚型.
- 皮他是TNBC患者没有病理完整反应 (pCR) 的标准辅助疗法.
- 新的治疗需要重新评估TNBC后的新辅助策略.
研究的目的:
- 审查新兴疗法在TNBC后的新辅助疗法的疗效.
- 将ICI,PARPis和ADC等新型药物与capecitabine进行比较.
- 为TNBC管理提供个性化医疗方法.
主要方法:
- 从关键临床试验和元分析中综合数据.
- 专注于免疫检查点抑制剂 (ICI),PARP抑制剂 (PARPis) 和抗体-药物结合剂 (ADC).
- 在TNBC治疗范式的背景下对治疗方法的评估.
主要成果:
- 抗胰岛素药物 (例如 pembrolizumab) 可以提高pCR率和无事件生存率.
- 在BRCA突变的TNBC中,PARPis显示出有效性,改善DFS和OS.
- 在残留疾病中,ADCs为capecitabine提供了潜在的替代品.
结论:
- 新兴疗法 (ICI,PARPis,ADCs) 为TNBC提供了对capecitabine的替代方案.
- 整合的挑战包括耐药性和患者因素.
- 未来的方向强调为残留疾病的TNBC患者提供个性化医疗.
关键词:
这是一种PARP抑制剂.辅助疗法是一种辅助疗法.抗体 药物联合体 抗体 药物联合体卡佩西塔宾 (capecitabine) 是一种药物.免疫疗法 免疫疗法新辅助疗法是一种新辅助疗法.三重阴性乳腺癌是什么更多相关视频
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.2K
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.0K
相关概念视频
01:27Tumor Immunotherapy
501
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
501
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
157
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
157
01:30Cancer Vaccines
348
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
348
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K